tradingkey.logo

Heartbeam Inc

BEAT
查看詳細走勢圖
2.978USD
-0.122-3.93%
交易中 美東報價延遲15分鐘
102.28M總市值
虧損本益比TTM

Heartbeam Inc

2.978
-0.122-3.93%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-3.93%

5天

+29.49%

1月

+281.34%

6月

+95.94%

今年開始到現在

+29.49%

1年

+22.56%

查看詳細走勢圖

TradingKey Heartbeam Inc股票評分

單位: USD 更新時間: 2025-10-27

操作建議

當前估值合理,機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價max_target_price。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Heartbeam Inc評分

相關信息

行業排名
159 / 204
全市場排名
468 / 4682
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 4 分析師
買入
評級
3.875
目標均價
+385.04%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Heartbeam Inc亮點

亮點風險
HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入0.00美元
估值合理
公司最新PE估值-2.32,處於3年歷史合理位
機構加倉
最新機構持股3.60M股,環比增加9.65%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉1.12M股

Heartbeam Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Heartbeam Inc簡介

HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
公司代碼BEAT
公司Heartbeam Inc
CEOEno (Robert P)
網址https://www.heartbeam.com/

常見問題

Heartbeam Inc(BEAT)的當前股價是多少?

Heartbeam Inc(BEAT)的當前股價是 2.978。

Heartbeam Inc 的股票代碼是什麼?

Heartbeam Inc的股票代碼是BEAT。

Heartbeam Inc股票的52週最高點是多少?

Heartbeam Inc股票的52週最高點是4.000。

Heartbeam Inc股票的52週最低點是多少?

Heartbeam Inc股票的52週最低點是0.540。

Heartbeam Inc的市值是多少?

Heartbeam Inc的市值是102.28M。

Heartbeam Inc的淨利潤是多少?

Heartbeam Inc的淨利潤為-19.45M。

現在Heartbeam Inc(BEAT)的股票是買入、持有還是賣出?

根據分析師評級,Heartbeam Inc(BEAT)的總體評級為買入,目標價格為3.875。

Heartbeam Inc(BEAT)股票的每股收益(EPS TTM)是多少

Heartbeam Inc(BEAT)股票的每股收益(EPS TTM)是-0.661。
KeyAI